Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Photochemotherapy beyond psoriasis

B Honig¹, W L Morison, D Karp

¹Johns Hopkins Medical Institutions, Baltimore, Maryland.

Journal of the American Academy of Dermatology

|November 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combining structural modeling and deep learning to calculate the E. coli protein interactome and functional networks.

Nature communications·2026

Same author

Combining structural modeling and deep learning to calculate the <i>E. coli</i> protein interactome and functional networks.

bioRxiv : the preprint server for biology·2025

Same author

A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors.

ESMO open·2024

Same author

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.

ESMO open·2021

Same author

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.

BMC cancer·2015

Same author

Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same journal

Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

Journal of the American Academy of Dermatology·2026

Same journal

First-Come, First-Served: Ethics of Coordinated Interview Releases.

Journal of the American Academy of Dermatology·2026

Same journal

Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

Journal of the American Academy of Dermatology·2026

Same journal

Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

Journal of the American Academy of Dermatology·2026

Same journal

Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

Journal of the American Academy of Dermatology·2026

Same journal

Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

Journal of the American Academy of Dermatology·2026

See all related articles

Psoralen photochemotherapy (PUVA) effectively treats over 30 skin conditions beyond psoriasis by utilizing light and photosensitizing chemicals. This therapy offers various mechanisms for beneficial effects in dermatological treatments.

Area of Science:

Dermatology and Photobiology
Photochemical reactions in medicine

Background:

Photochemotherapy combines nonionizing radiation with photosensitizing agents.
Psoralen photochemotherapy (PUVA) is a key treatment for psoriasis.
PUVA's success has spurred interest in treating other dermatoses.

Purpose of the Study:

To review the expanding applications of PUVA therapy in dermatology.
To discuss the mechanisms of action for PUVA treatment.
To identify limitations and future potential of PUVA.

Main Methods:

Review of existing literature on PUVA therapy for various dermatoses.
Discussion of mechanisms including photoimmunologic effects, cytotoxicity, and cellular function.
Analysis of treatment outcomes for over 30 conditions.

Related Experiment Videos

Main Results:

PUVA therapy has demonstrated success in treating more than 30 conditions.
Conditions treated include atopic dermatitis, mycosis fungoides, vitiligo, and others.
Mechanisms involve photoimmunologic effects, selective cytotoxicity, and melanocyte stimulation.

Conclusions:

Oral psoralen photochemotherapy is effective for a wide range of dermatological conditions.
Understanding treatment mechanisms can guide future therapeutic strategies.
Further research is warranted for expanding PUVA's use in cutaneous and systemic diseases.